Liquet Medical Inc.
PrivateLast Round
Seed Round
Mar 7, 2026
Total Funding Raised
$3.74M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Liquet Medical Inc. operates in Healthcare & Life Sciences and is based in Glen Allen, Virginia. Its latest recorded funding round was a Seed round in June 2025.
Liquet Medical Inc. is a medical device company that develops and commercializes novel technologies for the treatment of cardiovascular disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Liquet Medical Inc. Comparables
Compare Liquet Medical Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flow Medical Corporation | 89% | |
| Caeli Vascular, Inc. | 88% | |
| Thrombolex, Inc. | 88% |
For institutional investors. Book with your work email.
Liquet Medical Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 7, 2026 | ||||
| Seed | Jun 25, 2025 | ||||
| Seed | May 28, 2025 | ||||
| VC Round | Jul 6, 2023 | ||||
| Grant | May 18, 2023 | ||||
Seed | Apr 5, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Liquet Medical Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator, Seed |
| Virginia Venture Partners | VC Round |
| CAV Angels | Seed |
| Virginia Innovation Partnership Corporation | Seed, Grant |
| Virginia Catalyst | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 7, 2026
$75K Seed Round raised.
- May 28, 2025
$3.3M raised from CAV Angels and VIPC.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 3, 2026
Liquet Medical Inc. develops the Versus Catheter in Virginia, combining catheter-directed pulmonary embolism treatment with continuous pulmonary-artery pressure monitoring to give clinicians real-time insight, as of Sep '26.
For institutional investors. Book with your work email.
Liquet Medical Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Liquet Medical Inc.'s valuation, stock price, and market status.
Is Liquet Medical Inc. a public or private company?
Liquet Medical Inc. is a private company.
What is the current stock price of Liquet Medical Inc.?
Liquet Medical Inc. is a private company, so its shares have no public market price. Caplight tracks Liquet Medical Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Liquet Medical Inc. worth (valuation)?
Valuation information for Liquet Medical Inc. is not publicly available.
Can I buy Liquet Medical Inc. stock?
Liquet Medical Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Liquet Medical Inc.'s last funding round?
Liquet Medical Inc.'s most recent funding round was Seed Round on March 7, 2026.
Who are the main investors in Liquet Medical Inc.?
Key investors in Liquet Medical Inc. include MedTech Innovator, Virginia Venture Partners, CAV Angels, Virginia Innovation Partnership Corporation, Virginia Catalyst.
Will Liquet Medical Inc. IPO soon?
No public IPO plans have been announced for Liquet Medical Inc..
How can I track Liquet Medical Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Liquet Medical Inc.'s shares on secondary markets.